© 2024 Connecticut Public

FCC Public Inspection Files:
WEDH · WEDN · WEDW · WEDY
WECS · WEDW-FM · WNPR · WPKT · WRLI-FM · WVOF
Public Files Contact · ATSC 3.0 FAQ
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Rethinking weight and health in the age of Ozempic

A person using Ozempic on November 2, 2023, in Madrid, Spain. Novo Nordisk, the Danish firm that manufactures Ozempic, has reported record quarterly results, up almost 3% on the stock market. Ozempic is a diabetic drug that causes a loss of up to 15% of body weight because it acts as an appetite suppressant, a side effect that has made the drug fashionable on social media as a weight loss drug.
Ricardo Rubio
/
Europa Press via Getty Images
A person using Ozempic on November 2, 2023, in Madrid, Spain. Novo Nordisk, the Danish firm that manufactures Ozempic, has reported record quarterly results, up almost 3% on the stock market. Ozempic is a diabetic drug that causes a loss of up to 15% of body weight because it acts as an appetite suppressant, a side effect that has made the drug fashionable on social media as a weight loss drug.

According to the National Institutes of Health, average body weight drastically increased across the board for men and women during the pandemic lockdown.

Simply eating less and exercising more hasn’t been that effective when it comes to weight loss. In efforts to fight weight stigma, doctors are embracing a new idea that weight loss isn’t all about willpower and health is defined by more than just someone’s weight.

In 2021, the FDA approved Semaglutide for weight loss for the general population. Doctors and patients are flocking to get this medication.

Children over the age of 12 are now eligible to be prescribed this drug as well. Many celebrities have confirmed their personal use of the drugs, including Oprah. Influencers across the social sphere are partnering with pharmaceutical companies to promote the drugs.

Today, we talk about these drugs, and combating weight stigma in and out the doctor’s office.

GUESTS:

  • Dr. Mara Gordon: Family Practice Physician from New Jersey
  • Devika Umashanker: System Medical Director for Obesity Medicine at Hartford Healthcare
  • Dr. Maria Asnis: Director of the Center for Weight Management at Stamford Health
  • Dr. Sherry Pagoto: Licensed Clinical Psychologist and Professor at University of Connecticut

Where We Live is available as a podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, TuneIn, Listen Notes, or wherever you get your podcasts. Subscribe and never miss an episode.

Stay Connected
Tess is a senior producer for Connecticut Public news-talk show Where We Live. She enjoys hiking Connecticut's many trails and little peaks, knitting, gardening and writing in her seven journals.
Catherine is the Host of Connecticut Public’s morning talk show and podcast, Where We Live. Catherine and the WWL team focus on going beyond the headlines to bring in meaningful conversations that put Connecticut in context.